This is a tempting model for alterations in glucose import in response to transformation of normal astrocytes into astrocytomas/gliomas driven by a loss of Cx43, particularly as gliomas primarily obtain glucose through high expression of GLUT1/3 [204]. The gene discussed is SLC2A1; the disease is central nervous system cancer.